Hepion Pharmaceuticals, Inc. - Common Stock (HEPA)

Last Price0.4959

Change+0.0659 (15.33%)

NASDAQ · Last Trade: Apr 11th, 10:57 AM EDT

Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment

Renocofilstat's Positive Outcomes Reinforce Antifibrotic Action Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focusing on AI-assisted therapeutic drug development, recently

Via Spotlight Growth · May 22, 2023